Cancer-bearing mice were found to have increased the expression of CCL2 in cancer cells and the infiltration of MDSCs into cancer tissues; blocking CCL2 decreased MDSC, both in serum and in tissues, and improved their prognosis [92]. The gene discussed is CCL2; the disease is cancer.